Diagnos, Inc. (ADK.V)
0.41
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 15:35
Diagnos Shareholders Equity (Quarterly) : 0.6869M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.6869M |
| December 31, 2025 | 1.496M |
| September 30, 2025 | -1.537M |
| June 30, 2025 | -0.8017M |
| March 31, 2025 | 0.2331M |
| December 31, 2024 | -0.4772M |
| September 30, 2024 | -0.9147M |
| June 30, 2024 | -2.439M |
| March 31, 2024 | -3.052M |
| December 31, 2023 | -2.882M |
| September 30, 2023 | -2.752M |
| June 30, 2023 | -2.277M |
| March 31, 2023 | -1.948M |
| December 31, 2022 | -1.519M |
| September 30, 2022 | -1.210M |
| June 30, 2022 | -0.7973M |
| March 31, 2022 | -0.1135M |
| December 31, 2021 | 0.2163M |
| September 30, 2021 | 0.7174M |
| June 30, 2021 | 1.010M |
| March 31, 2021 | 1.132M |
| December 31, 2020 | 1.167M |
| September 30, 2020 | 1.002M |
| June 30, 2020 | 1.349M |
| March 31, 2020 | 1.819M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.3703M |
| September 30, 2019 | 0.0375M |
| June 30, 2019 | -0.0035M |
| March 31, 2019 | -5.083M |
| December 31, 2018 | -4.348M |
| September 30, 2018 | -5.302M |
| June 30, 2018 | -4.572M |
| March 31, 2018 | -3.637M |
| December 31, 2017 | -2.379M |
| September 30, 2017 | -2.344M |
| June 30, 2017 | -1.524M |
| March 31, 2017 | -2.914M |
| December 31, 2016 | -2.710M |
| September 30, 2016 | -3.460M |
| June 30, 2016 | -3.557M |
| March 31, 2016 | -3.149M |
| December 31, 2015 | -1.975M |
| September 30, 2015 | -1.256M |
| June 30, 2015 | -0.8683M |
| March 31, 2015 | -0.2248M |
| December 31, 2014 | 0.4423M |
| September 30, 2014 | 1.113M |
| June 30, 2014 | -0.2967M |
| March 31, 2014 | 0.347M |
| December 31, 2013 | 0.767M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Evokai Creative Labs, Inc. | -- |
| Arch Biopartners, Inc. | -3.644M |
| Avricore Health, Inc. | 0.1952M |
| Kane Biotech, Inc. | -1.418M |
| CardioComm Solutions, Inc. | -0.6894M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.390M |
| Total Liabilities (Quarterly) | 1.704M |
| Debt to Equity Ratio | 2.040 |
| Current Ratio | 1.489 |
| Net Debt Paydown Yield | 1.14% |